The National Institute of Mental Health (NIMH) recently announced their funding of a randomized, placebo controlled study that will investigate the efficacy of neurofeedback for attention deficit hyperactivity disorder (ADHD). The research group is from Ohio State University.
The study will include boys and girls with ADHD from ages 6-11. Participants will be randomly assigned to receive actual neurofeedback (“experimental group”) or simulated neurofeedback (“placebo group”). As mentioned in the recent write up, additional neurofeedback research is needed across the board so this is a welcome announcement. A bonus is that this is a NIMH study which lends additional creditability to the outcome. Personal experience suggests that these Ohio State researchers will find significant reductions in ADHD symptoms as attention and concentration seem to improve in many patients following neurotherapy, regardless of diagnosis. You can find the NIMH announcement here.